Geopolitics Drives Pharma Network Reconfiguration

We are not optimizing supply chains anymore—we are securing them.

Regional hubs. Dual sourcing. Multi-network setups. On paper, this increases resilience. In practice, it introduces complexity at a level many organizations are not fully prepared for. More nodes mean more handovers. More handovers mean more variability. More variability means more risk. And all of this still needs to comply with GDP.
From what I see, the strategic decision is often made at a high level. But the operational impact lands in logistics—and is not always fully understood.
Lead times become less predictable. Oversight becomes harder. Qualification efforts multiply. The real question is not whether regionalization is right. It is already happening.

But it  is: can we operate these networks reliably? Because complexity is manageable—until it isn’t.

Let’s exchange views—join our LinkedIn profile or connect via https://www.ipharmalogistics.com/contact-us‍ ‍